ResearcherKaiser PermanenteNo recent work listed

Robert Michael Cooper

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7482-828X; OpenAlex author ID A5019984038. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2015: 1 paper

Papers 1

Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer. Last author DOI 10.1038/ajg.2015.217 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Brian Z. Huang · 1 shared paper, 2015 · strength 0.05
- Paper Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer. DOI 10.1038/ajg.2015.217 ↗
Jonathan I. Chang · 1 shared paper, 2015 · strength 0.05
- Paper Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer. DOI 10.1038/ajg.2015.217 ↗
Christie Y. Jeon · 1 shared paper, 2015 · strength 0.05
- Paper Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer. DOI 10.1038/ajg.2015.217 ↗
Stephen Jacob Pandol · 1 shared paper, 2015 · strength 0.05
- Paper Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer. DOI 10.1038/ajg.2015.217 ↗
Bechien U. Wu · 1 shared paper, 2015 · strength 0.05
- Paper Impact of statin use on survival in patients undergoing resection for early-stage pancreatic cancer. DOI 10.1038/ajg.2015.217 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.